ABA's Antitrust Magazine
The FDA’s and FTC’s Increased Focus on Generic Drug Competition Signals Enhanced Attention to REMS IssuesExternal Article
ABA’s Antitrust Health Care Chronicle
Association of Corporate Counsel CLE
Moderator, Platform Regulation and Antitrust
Baker Botts will host a comprehensive CLE program in our Washington office on October 24, 2017.